We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma.
- Authors
Gunda, Venugopal; Pathania, Anup S.; Chava, Srinivas; Prathipati, Philip; Chaturvedi, Nagendra K.; Coulter, Don W.; Pandey, Manoj K.; Durden, Donald L.; Challagundla, Kishore B.
- Abstract
Simple Summary: Neuroblastomas mostly show poor response to the Cisplatin therapy. Amino acids serve as building blocks for proteins, which are acquired either through diet or protein breakdown. Our study reveals high amino acid pools and dependence of Cisplatin-tolerant neuroblastomas cells on amino acids for their survival, especially, in drug treated conditions. Our study also demonstrates that response of neuroblastomas to Cisplatin can be improved by decreasing cellular amino acid levels either by reducing amino acid supplements or by applying autophagy inhibitor, Hydroxychloroquine. Thus, our findings establish that neuroblastomas can be sensitized to Cisplatin by targeting amino acid metabolism. Neuroblastoma are pediatric, extracranial malignancies showing alarming survival prognosis outcomes due to their resilience to current aggressive treatment regimens, including chemotherapies with cisplatin (CDDP) provided in the first line of therapy regimens. Metabolic deregulation supports tumor cell survival in drug-treated conditions. However, metabolic pathways underlying cisplatin-resistance are least studied in neuroblastoma. Our metabolomics analysis revealed that cisplatin-insensitive cells alter their metabolism; especially, the metabolism of amino acids was upregulated in cisplatin-insensitive cells compared to the cisplatin-sensitive neuroblastoma cell line. A significant increase in amino acid levels in cisplatin-insensitive cells led us to hypothesize that the mechanisms upregulating intracellular amino acid pools facilitate insensitivity in neuroblastoma. We hereby report that amino acid depletion reduces cell survival and cisplatin-insensitivity in neuroblastoma cells. Since cells regulate their amino acids levels through processes, such as autophagy, we evaluated the effects of hydroxychloroquine (HCQ), a terminal autophagy inhibitor, on the survival and amino acid metabolism of cisplatin-insensitive neuroblastoma cells. Our results demonstrate that combining HCQ with CDDP abrogated the amino acid metabolism in cisplatin-insensitive cells and sensitized neuroblastoma cells to sub-lethal doses of cisplatin. Our results suggest that targeting of amino acid replenishing mechanisms could be considered as a potential approach in developing combination therapies for treating neuroblastomas.
- Subjects
AMINO acid metabolism; AUTOPHAGY; AMINO acids; ANIMAL experimentation; ANTINEOPLASTIC agents; CELL lines; CHLOROQUINE; CISPLATIN; DRUG resistance in cancer cells; MICE; NEUROBLASTOMA; TRANSCRIPTION factors; CELL survival; METABOLOMICS; PHARMACODYNAMICS
- Publication
Cancers, 2020, Vol 12, Issue 9, p2576
- ISSN
2072-6694
- Publication type
Article
- DOI
10.3390/cancers12092576